D. E. Shaw & Co., Inc. Assertio Holdings, Inc. Transaction History

D. E. Shaw & Co., Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.79 - $1.14 $117,465 - $169,506	-148,690 Reduced 49.59%	151,162 $145,000
Q3 2023 Nov 14, 2023	SELL	$2.52 - $5.69 $642,229 - $1.45 Million	-254,853 Reduced 45.94%	299,852 $767,000
Q2 2023 Aug 14, 2023	SELL	$5.0 - $7.66 $529,300 - $810,887	-105,860 Reduced 16.03%	554,705 $3.01 Million
Q1 2023 May 15, 2023	BUY	$3.54 - $6.66 $567,508 - $1.07 Million	160,313 Added 32.05%	660,565 $4.21 Million
Q4 2022 Feb 14, 2023	BUY	$2.11 - $4.3 $44,470 - $90,626	21,076 Added 4.4%	500,252 $2.15 Million
Q3 2022 Nov 14, 2022	BUY	$2.13 - $4.0 $440,053 - $826,392	206,598 Added 75.79%	479,176 $1.09 Million
Q2 2022 Aug 15, 2022	BUY	$1.88 - $3.42 $394,642 - $717,912	209,916 Added 335.0%	272,578 $804,000
Q1 2022 May 16, 2022	BUY	$2.06 - $3.0 $97,250 - $141,627	47,209 Added 305.5%	62,662 $180,000
Q4 2021 Feb 14, 2022	SELL	$0.86 - $2.3 $39,352 - $105,245	-45,759 Reduced 74.75%	15,453 $34,000
Q3 2021 Nov 15, 2021	SELL	$0.89 - $1.55 $16,079 - $28,003	-18,067 Reduced 22.79%	61,212 $55,000
Q2 2021 Aug 16, 2021	BUY	$1.48 - $2.88 $117,332 - $228,323	79,279 New	79,279 $124,000

31M

957K

38.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $44.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.